阿尔茨海默病的早期诊断基于多重注意力机制
Xinli Yang1, Kefen Hong2, Denghui Zhang1
1College of Information Technology, Zhejiang Shuren University, Hangzhou, Zhejiang, China.
PloS one
|September 24, 2024
概括
这项研究引入了一个新的模型,EDAMM,用于早期阿尔茨海默氏症.
科学领域:
- 神经退行性疾病 神经退行性疾病
- 医疗保健中的人工智能
- 计算语言学 计算语言学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病.
- 语言障碍是阿尔茨海默病的关键早期症状,强调了早期检测的必要性.
- 目前用于AD诊断的多式联络数据分析面临复杂性和特征提取方面的挑战.
研究的目的:
- 开发和评估一种新的模型,即基于多模式注意力的早期诊断 (EDAMM),用于早期检测阿尔茨海默病.
- 解决从复杂和不一致的多式联运数据中提取特征的局限性.
- 通过使用集成的语音和文本信息来提高AD诊断的准确性.
主要方法:
- 使用Wav2Vec2.0,TF-IDF和Word2Vec来实现最佳的声学和语言特征提取.
- 采用自我注意力和跨模态注意力机制来产生融合的特征,捕捉跨模态相关性.
- 将特征集成到一个复合向量中,用于使用神经网络 (NN) 进行分类.
主要成果:
- 拟议的EDAMM模型在阿尔茨海默氏症诊断方面表现得更好.
- 在NCMMSC2021和ADReSSo数据集上进行的实验证实了EDAMM的有效性.
- 在诊断准确度方面,EDAMM的表现优于现有的最先进的基线方法.
结论:
- EDAMM模型为早期阿尔茨海默病诊断提供了一个有希望的方法.
- 多模式注意力机制有效地增强特征表示和跨模式相关性捕获.
- 这种方法显示出临床应用在早期识别阿尔茨海默氏症的重大潜力.
相关概念视频
01:26Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170